Alpha 2.0
Login Register
» Authors » Paneerselvam Nandagopal

Paneerselvam Nandagopal

Explore the profile of Paneerselvam Nandagopal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 85
Followers 0
Related Specialties
Infectious Diseases
Biology
Microbiology
Top 10 Co-Authors
Aylur K Srikrishnan
Sunil S Solomon
Shruti H Mehta
Mark S Sulkowski
Gregory M Lucas
M Suresh Kumar
Sunil Suhas Solomon
David L Thomas
Shanmugam Saravanan
Allison M McFall
Published In
Open Forum Infect Dis
Clin Infect Dis
Int J Drug Policy
Elife
J Acquir Immune Defic Syndr
Affiliations
Soon will be listed here.
Recent Articles
1.
Deep learning and social network analysis elucidate drivers of HIV transmission in a high-incidence cohort of people who inject drugs
Clipman S, Mehta S, Mohapatra S, Srikrishnan A, Zook K, Duggal P, et al.
Sci Adv . 2022 Oct; 8(42):eabf0158. PMID: 36260674
Globally, people who inject drugs (PWID) experience some of the fastest-growing HIV epidemics. Network-based approaches represent a powerful tool for understanding and combating these epidemics; however, detailed social network studies...
2.
Performance characteristics of two new rapid HIV diagnostic assays and use of test band reader
Selvakumar M, Nandagopal P, Kumar M, Aditya N, Solomon S, Saravanan S, et al.
Indian J Med Microbiol . 2022 Jun; 40(3):370-373. PMID: 35680473
Purpose: Accurate HIV diagnosis is essential for appropriate patient care. This present study evaluated the performance of two different new rapid HIV diagnostic tests; 1) TRUSTline HIV-1/2 Ab rapid test...
3.
Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India
Clipman S, Mehta S, Srikrishnan A, Zook K, Duggal P, Mohapatra S, et al.
Elife . 2021 Aug; 10. PMID: 34342266
Background: People who inject drugs (PWID) account for some of the most explosive human immunodeficiency virus (HIV) and hepatitis C virus (HCV) epidemics globally. While individual drivers of infection are...
4.
Performance characteristics of an instrument-free point-of-care CD4 test (VISITECT®CD4) for use in resource-limited settings
Vidhyavathi V, Iqbal H, Kanthamani K, Solomon S, Nandagopal P, Luchters S, et al.
J Int Med Res . 2020 Sep; 48(9):300060520955028. PMID: 32985310
Objective: CD4+ T lymphocyte count remains the most common biomarker of immune status and disease progression in human immunodeficiency virus (HIV)-positive individuals. VISITECT®CD4 is an instrument-free, low-cost point-of-care CD4 test...
5.
Brief Report: The Anti-HIV-1 ADCC-Mediating Antibodies From Cervicovaginal Secretions of HIV-Infected Women Have an Ability to Mediate Lysing of Autologous CD4+ HIV-Infected Cells
Dhande J, Angadi M, Murugavel K, Poongulali S, Nandagopal P, Vignesh R, et al.
J Acquir Immune Defic Syndr . 2018 Sep; 79(2):277-282. PMID: 30211779
Background: Fragment crystallizable region of antibody-mediated mechanism such as antibody-dependent cellular cytotoxicity (ADCC) has been identified as an important component of immune protection against HIV. We assessed whether the anti-HIV...
6.
Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India
Patel E, Solomon S, McFall A, Srikrishnan A, Pradeep A, Nandagopal P, et al.
Int J Drug Policy . 2018 Apr; 57:51-60. PMID: 29679811
Background: Little is known regarding barriers to hepatitis C virus (HCV) treatment among people who inject drugs (PWID) in low-resource settings, particularly in the era of direct-acting antiviral therapies. Methods:...
7.
Broad neutralization response in a subset of HIV-1 subtype C-infected viraemic non-progressors from southern India
Nandagopal P, Bhattacharya J, Srikrishnan A, Goyal R, Swathirajan C, Patil S, et al.
J Gen Virol . 2018 Feb; 99(3):379-392. PMID: 29458681
Broadly neutralizing antibodies (bnAbs) have been considered to be potent therapeutic tools and potential vaccine candidates to enable protection against various clades of human immunodeficiency virus (HIV). The generation of...
8.
Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India
Cepeda J, Solomon S, Srikrishnan A, Nandagopal P, Balakrishnan P, Kumar M, et al.
Open Forum Infect Dis . 2016 Oct; 3(3):ofw156. PMID: 27704012
 Access to hepatitis C virus (HCV) treatment is limited in low- and middle-income countries (LMICs). Noninvasive biomarkers, such as fibrosis 4 (FIB-4) and aminotransferase to platelet ratio index (APRI), are...
9.
Morbidity and Mortality Among Community-Based People Who Inject Drugs With a High Hepatitis C and Human Immunodeficiency Virus Burden in Chennai, India
Mehta S, McFall A, Srikrishnan A, Suresh Kumar M, Nandagopal P, Cepeda J, et al.
Open Forum Infect Dis . 2016 Jul; 3(3):ofw121. PMID: 27419185
Background.  There are limited data on clinical outcomes of hepatitis C virus (HCV) infection from low- and middle-income countries. We characterize mortality and liver disease progression in a cohort of...
10.
HIV care continuum among men who have sex with men and persons who inject drugs in India: barriers to successful engagement
Mehta S, Lucas G, Solomon S, Srikrishnan A, McFall A, Dhingra N, et al.
Clin Infect Dis . 2015 Aug; 61(11):1732-41. PMID: 26251048
Background: We characterize the human immunodeficiency virus (HIV) care continuum for men who have sex with men (MSM) and persons who inject drugs (PWID) across India. Methods: We recruited 12...